Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated (VRTX $441.11)
- $441.11 P/E (TTM): 29.06X Cap: $112.39B
- View VRTX Profile
- View Questions on VRTX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $458.56)
- $458.56 P/E (TTM): 59.37X Cap: $166.32B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $441.11)
- $441.11 P/E (TTM): 29.06X Cap: $112.39B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $208.25)
- $208.25 P/E (TTM): 89.09X Cap: $368.64B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $233.99)
- $233.99 P/E (TTM): 21.77X Cap: $574.86B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $905.46)
- $905.46 P/E (TTM): 40.2X Cap: $855.08B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $115.92)
- $115.92 P/E (TTM): 16.48X Cap: $291.36B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $174.52)
- $174.52 P/E (TTM): 20.63X Cap: $8.52B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $576.74)
- $576.74 P/E (TTM): 44.65X Cap: $46.18B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $67.68)
- $67.68 P/E (TTM): 26.6X Cap: $8.06B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $95.88)
- $95.88 P/E (TTM): 15.24X Cap: $19.32B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $25.77)
- $25.77 P/E (TTM): 15.5X Cap: $3.15B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $28.18)
- $28.18 P/E (TTM): 369.61X Cap: $235.79B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

Vertex Pharmaceuticals Incorporated (VRTX $441.11)
- $441.11 P/E (TTM): 29.06X Cap: $112.39B
- View VRTX Profile
- View Questions on VRTX
CRISPR Therapeutics AG (CRSP $55.46)
- $55.46 Cap: $5.47B
- View CRSP Profile
- View Questions on CRSP

Q: What is your opinion regarding the future of CRSP? Buy, sell, hold?

Read Answer Asked by Judith on May 21, 2025

Vertex Pharmaceuticals Incorporated (VRTX $441.11)
- $441.11 P/E (TTM): 29.06X Cap: $112.39B
- View VRTX Profile
- View Questions on VRTX

Q: May I please get your thoughts on this company? I like their new non-opioid pain killer that was just approved by the FDA for a strong growth prospect. I am curious what you think about the existing business and the fundamentals/financials of the company. Thanks.

Read Answer Asked by Marco on February 14, 2025